Join the Lymphoma Hub live symposium at ICML 2025: Customizing therapy for MCL

Join us for the Lymphoma Hub live symposium: ‘Customizing therapy for MCL’ at the 18th International Conference on Malignant Lymphoma (ICML) in Lugano, CH, on June 17, 2025, from 16:30 to 18:00 CEST.  

This symposium will focus on customizing therapy for mantle cell lymphoma (MCL), highlighting unmet needs and the latest in treatment strategies. Esteemed speakers Gilles Salles, Julie Vose, Wojciech Jurczak, and Michael Wang, will delve into sequencing therapies, managing adverse events, and exploring novel therapies. Engage in interactive case studies and gain insights into the future of Bruton’s tyrosine kinase (BTK) inhibition and chimeric antigen receptor (CAR) T-cell therapies. The session will close with a live Q&A session, providing the opportunity to engage directly with our expert panelists. 

By attending this symposium, you may receive 1.5 CME credits (pending approval).

Don’t miss this opportunity to enhance your understanding of MCL treatment landscapes, register for the 18th ICML.

Sign up to our newsletter to hear the latest updates on this event and more. 

This independent educational activity was supported by Eli Lilly and Company. All content was developed by SES in collaboration with the faculty; funders were allowed no influence on the content of this activity. 

If you are interested in supporting future events like this one, then please get in touch with our partnerships team.